Clinical trials
Phase 1 trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 10 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laboratorios Andromaco S.A. | 12 |
| Merck Sharp & Dohme LLC | 7 |
| Pontificia Universidad Catolica de Chile | 5 |
| Bristol-Myers Squibb | 3 |
| Universidad de los Andes, Chile | 3 |
| University of Chile | 3 |
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
| MedImmune LLC | 2 |
| Universidad de Valparaiso | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 6 |
| Melanoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Aortic Aneurysm, Abdominal | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colorectal Neoplasms | 2 |
| Respiratory Syncytial Virus Infections | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.